145 related articles for article (PubMed ID: 34880028)
1. Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial.
Eom BW; Koo DH; An JY; Lee HH; Kim HI; Hur H; Yoo MW; Ryu MH; Lee HJ; Kim SM; Park JH; Min JS; Seo KW; Jeong SH; Jeong O; Kwon OK; Ryu SW; Yoo CH; Bae JM; Ryu KW
BMJ Open; 2021 Dec; 11(12):e056187. PubMed ID: 34880028
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral immunonutritional supplement on 3-year disease-free survival in gastric cancer patients with pathological stage III after total gastrectomy (CRUCIAL): study protocol of a multicentre, randomised clinical trial.
Zhou D; Liu Y; Zhang L; Lu M; Gao X; Li G; Xiang X; Xu H; Li G; Sun Z; Wei W; Yi K; Zuo J; Wu Y; Qian J; Zhou J; Duan K; Wu Y; Tian Z; Jiang C; Wang X
BMJ Open; 2023 Apr; 13(4):e067990. PubMed ID: 37041057
[TBL] [Abstract][Full Text] [Related]
3. Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial.
Cui H; Cao B; Liu G; Xi H; Chen Z; Liang W; Zhang K; Cui J; Xie T; Deng H; Tang Y; Chen L; Wei B
BMJ Open; 2021 May; 11(5):e043535. PubMed ID: 34035091
[TBL] [Abstract][Full Text] [Related]
4. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765).
Nickel F; Studier-Fischer A; Hausmann D; Klotz R; Vogel-Adigozalov SL; Tenckhoff S; Klose C; Feisst M; Zimmermann S; Babic B; Berlt F; Bruns C; Gockel I; Graf S; Grimminger P; Gutschow CA; Hoeppner J; Ludwig K; Mirow L; Mönig S; Reim D; Seyfried F; Stange D; Billeter A; Nienhüser H; Probst P; Schmidt T; Müller-Stich BP
BMJ Open; 2022 Oct; 12(10):e064286. PubMed ID: 36316075
[TBL] [Abstract][Full Text] [Related]
6. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
7. Effect of different oesophagojejunostomy methods on the quality of life of gastric cancer patients after totally laparoscopic total gastrectomy with self-pulling and latter transected technique: study protocol for a randomised trial.
Wang J; Tseng Y; Hong J; Hua LC; Wang YP; Hao HK
BMJ Open; 2022 Apr; 12(4):e058844. PubMed ID: 35428644
[TBL] [Abstract][Full Text] [Related]
8. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Lang J; Cheng A; Li W
BMJ Open; 2019 Jul; 9(7):e029055. PubMed ID: 31362966
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
11. Multimodal prehabilitation to improve the clinical outcomes of frail elderly patients with gastric cancer: a study protocol for a multicentre randomised controlled trial (GISSG
Sun Y; Tian Y; Cao S; Li L; Yu W; Ding Y; Wang X; Kong Y; Wang X; Wang H; Hui X; Qu J; Wang H; Duan Q; Yang D; Zhang H; Zhou S; Liu X; Li Z; Meng C; Kehlet H; Zhou Y
BMJ Open; 2023 Oct; 13(10):e071714. PubMed ID: 37816552
[TBL] [Abstract][Full Text] [Related]
12. Using patient-reported outcomes to manage postoperative symptoms in patients with lung cancer: protocol for a multicentre, randomised controlled trial.
Dai W; Zhang Y; Feng W; Liao X; Mu Y; Zhang R; Wei X; Wu C; Xie S; Li Q; Shi Q
BMJ Open; 2019 Aug; 9(8):e030041. PubMed ID: 31455710
[TBL] [Abstract][Full Text] [Related]
13. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
[TBL] [Abstract][Full Text] [Related]
14. Postoperative complications and nutritional status between uncut Roux-en-Y anastomosis and Billroth II anastomosis after D2 distal gastrectomy: a study protocol for a multicenter randomized controlled trial.
Chen S; Chen DW; Chen XJ; Lin YJ; Xiang J; Peng JS
Trials; 2019 Jul; 20(1):428. PubMed ID: 31300019
[TBL] [Abstract][Full Text] [Related]
15. Effects of perioperative enhanced recovery after surgery pathway management versus traditional management on the clinical outcomes of laparoscopic-assisted radical resection of distal gastric cancer: study protocol for a randomized controlled trial.
Tian Y; Cao S; Li L; He Q; Xia L; Jiang L; Ding Y; Wang X; Wang H; Mao W; Hui X; Shi Y; Zhang H; Chu X; Kehlet H; Zhou Y
Trials; 2020 May; 21(1):369. PubMed ID: 32357913
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
18. SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial.
Billingy NE; Tromp VNMF; Veldhuijzen E; Belderbos J; Aaronson NK; Feldman E; Hoek R; Bogaard HJ; Onwuteaka-Philipsen BD; van de Poll-Franse L; Hugtenburg JG; van den Hurk CJG; Becker-Commissaris A; Walraven I
BMJ Open; 2021 Sep; 11(9):e052494. PubMed ID: 34518276
[TBL] [Abstract][Full Text] [Related]
19. A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).
Lee CM; Park JH; In Choi C; Lee HH; Min JS; Jee YS; Jeong O; Chae H; Choi SI; Huang H; Park S
BMC Cancer; 2019 Mar; 19(1):206. PubMed ID: 30845995
[TBL] [Abstract][Full Text] [Related]
20. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
